V. Correia

发表

NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.

João Trigueiro-Louro, Luís A. Santos, Filipe Almeida, 2021, Virology.

Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2

L. Branco, Miguel M. Santos, Ž. Petrovski, 2022, Pharmaceutics.

Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.

A. Abecasis, V. Correia, H. Rebelo-de-Andrade, 2018, Virology.

Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons.

M. Zambon, A. Lackenby, Luís A. Santos, 2010, Antiviral research.

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike

João Trigueiro-Louro, V. Correia, H. Rebelo-de-Andrade, 2020, Computational and Structural Biotechnology Journal.

Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity

H. Rebelo de Andrade, J. Lavinha, B. Nunes, 2017, Immunogenetics.

To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.

R. Guedes, João Trigueiro-Louro, Luís A. Santos, 2019, Virology.

“How to dissect viral infections and their interplay with the host-proteome by immunoaffinity and mass spectrometry: A tutorial.”

H. Santos, J. Capelo, C. Lodeiro, 2022, Microchemical Journal.

Influenza virus susceptibility to antiviral drugs : drug susceptibility profiling, whole-genome mutational landscape and selective pressure footprints

V. Correia, 2018 .

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013

Dayan Wang, L. Gubareva, A. Hurt, 2014, Antiviral research.

Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity

H. Rebelo de Andrade, J. Lavinha, B. Nunes, 2018, Immunogenetics.

Influenza A(H1N1)pdm09 resistance and cross‐decreased susceptibility to oseltamivir and zanamivir antiviral drugs

Luís A. Santos, V. Correia, H. Rebelo-de-Andrade, 2015, Journal of medical virology.

Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.

H. Rebelo de Andrade, S. Pedro, Luís A. Santos, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.